About
About Epitalon Compound
Who publishes this, what it is, and — just as important — what it is not.
What this site is
Epitalon Compound is an independent editorial project that publishes summaries of the peer-reviewed research literature on Epitalon, the synthetic AEDG tetrapeptide. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science — a careful reading of what the studies measured, organized so a non-specialist can follow it without losing the technical detail underneath.
What the name means
The "compound" in Epitalon Compound is editorial framing, not a claim about services. It signals that this is a research-literature publication concerned with a specific chemical compound — its mechanisms, its studies, its open questions — rather than a storefront or a treatment service. We occupy a position relative to the literature: that of an attentive reader who weighs claims against evidence. We do not occupy any position relative to your health. Nothing here is a prescription, a consultation, or an endorsement of using the compound.
How we handle the evidence
Our editorial stance on Epitalon is set by the shape of its evidence base. The findings are real and specific, but they originate overwhelmingly from a single research lineage and rest on animal and cell work plus uncontrolled human observation. We therefore present preclinical results as preclinical, claims as claims, and we foreground the single-laboratory attribution and the investigational, unapproved status of the compound on every page. We cite every quantitative statement to a primary source, we distinguish Epitalon from its parent extract epithalamin, and we give no human dosing. When the evidence is strong we say so plainly; when it is thin we say that too.
Corrections and accuracy
This is a digest of a living literature, and the literature on Epitalon is actively changing — the most important recent additions, an independent replication and a systematic review, both arrived in 2025. We update as new peer-reviewed work appears, and we aim to represent each study as its authors framed it, including its limitations. If a summary here misstates a finding or a citation, that is an error we want to fix. The contact page explains how to reach us about the content.